JC
KDNY

JBF Capital’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

JBF Capital’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-11,500
Closed -$442K – 81
2023
Q2 		$442K Buy
+11,500
New +$295K 0.09% 40

JBF Capital's KDNY Position: Q3 2023 in Review

JBF Capital sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 11,500 shares — an estimated $442K sold.

JBF Capital first reported a position in KDNY in Q2 2023 and held it in 1 quarter. The position peaked at $442K in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

  • JBF Capital reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • JBF Capital sold 11,500 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $442K.
  • JBF Capital first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • JBF Capital's Chinook Therapeutics, Inc. Common Stock position peaked at $442K in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on JBF Capital's 13F filing for Q3 2023, filed 14 Nov 2023.